| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.1 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |